Matthew Hadfield, DO, discusses findings from a phase 2 study that used tocilizumab to reduce toxicities with immune checkpoint inhibitors in melanoma.
2025
Insight on Treating Patients With Melanoma With Brain Metastases
Panelists discuss how treating patients with melanoma and brain metastases requires a multidisciplinary approach, emphasizing the role of immunotherapy, targeted therapy, and local treatments, while considering factors like the extent of metastasis and patient-specific factors.
Cutaneous Melanoma Risk Elevated for Survivors of Specific Cancers
MONDAY, Dec. 23, 2024 (HealthDay News) — Specific cancers are associated with an increased risk for developing subsequent cutaneous melanoma, according to a study published in the January issue of JID Innovations.
As melanoma deaths increase, new documentary tells Australian stories
Two out of three Australians will get skin cancer at some point in their lives, according to the Cancer Council.